Matrix metalloproteinases in the oral fluid as a characteristic of inflammatory-destructive process in periodontal tissues

Авторы

DOI:

https://doi.org/10.26641/2307-0404.2022.3.265959

Ключевые слова:

generalized periodontitis, pathogenesis, diagnosis, matrix metalloproteinases

Аннотация

The study of the imbalance between the activity of matrix metalloproteinases and their regulation markers in the oral fluid of patients with generalized periodontitis is necessary for creation of effective methods for early diagnosis and preventive treatment of the disease. The aim of the research was to examine the oral fluid of persons with healthy periodontal tissues, patients with chronic diffuse gingivitis and generalized periodontitis for concentrations of matrix metalloproteinases and their inhibitor, anti- and pro-inflammatory cytokines, markers of bone metabolism and to compare obtained results. 90 persons aged 32-45 years were examined, including 30 persons with intact periodontal tissues, 30 patients with chronic diffuse catarrhal gingivitis and generalized periodontitis of the initial degree and 30 ones with chronic generalized periodontitis of I-II degrees. Periodontal status was assessed using clinical indices and bone mineral density according to computed tomography data. The method of enzyme-linked immunosorbent assay (ELISA) was used to determine the concentration of matrix metalloproteinases MMP-2, MMP-3, MMP-8, MMP-9, MMP-13, tissue inhibitor of metalloproteinases TIMP-1, interleukins-1β, -6 and -4, bone metabolism markers – tartrate-resistant acidic phosphatase and bone alkaline phosphatase, osteocalcin in the oral fluid. The initiation of the inflammatory-destructive process in the periodontal tissues was characterized by an increase levels of MMP and pro-inflammatory IL-1β and IL-6 (р<0.05), a decrease in the concentration of TIMP-1 (р>0.05) and anti-inflammatory IL-4 (р<0.05), against the background of the absence of dynamics of bone metabolism markers in the oral fluid. The progression of the process at the І-II degrees of periodontitis was accompanied by a further increase in the concentration of pro-inflammatory interleukins, an increase in the activity of tartrate-resistant acid phosphatase and a decrease in bone alkaline phosphatase and osteocalcin (р<0.05) in the oral fluid, while the content of MMP did not change (р>0.05). The expression of MMP is important for the preventive diagnosis of generalized periodontitis, but it is not indicative for determining the severity of the disease. The imbalance of MMP and TIMP-1 in the early stages of the pathological process indicates the greatest expediency of using MMP inhibitors in the treatment of patients with gingivitis and periodontitis of the initial degree.

Библиографические ссылки

Antomonov MY. [Mathematical processing and analysis of biomedical data]. Kyiv; 2017. Russian.

Vozna IV, Samoilenko AV, Pavlov SV. [Study of the content of biochemical markers of bone metabolism in the oral fluid of patients with generalized periodontitis]. Ukrainskyi stomatolohichnyi almanakh. 2020;4:10-14. Ukrainian. doi: https://doi.org/10.31718/2409-0255.4.2020.02

Danilevsky MF, Borisenko AV, Antonenko MY. [Therapeutic dentistry]. Kyiv: VSV «Medytsyna»; 2018. Ukrainian.

Fastovets OO, Lucash AY. [Matrix metalloprotei-nase-8 in the early diagnosis of generalized periodontitis]. Zaporozhye Medical Journal; 2018;5(110):723-8. Ukrainian.

Abusleme L, Hoare A, Hong BY, Diaz PI. Micro-bial signatures of health, gingivitis, and periodontitis. Periodontol 2000. 2021;86(1):57-78. doi: https://doi.org/10.1111/prd.12362

Baddam H, Vivekanandan G, Kondreddy K, Peddi S, Chitnis PP, Singh YP, et al. Evaluation of gingival crevicular fluid and serum tartrate-resistant acid phos-phatase levels in subjects with clinically healthy periodontium and chronic periodontitis: A clinical-biochemical study. J Pharm Bioallied Sci. 2021;13(Suppl 2):1275-9. doi: https://doi.org/10.4103/jpbs.jpbs_90_21

Bostanci N, Mitsakakis K, Afacan B, Bao K, Johannsen B, Baumgartner D, et al. Validation and verifi-cation of predictive salivary biomarkers for oral health. Sci Rep. 2021;11(1):6406. doi: https://doi.org/10.1038/s41598-021-85120-w

Cafiero C, Spagnuolo G, Marenzi G, Martuscelli R, Colamaio M, Leuci S. Predictive periodontitis: the most promising salivary biomarkers for early diagnosis of periodontitis. J Clin Med. 2021;10(7):1488. doi: https://doi.org/10.3390/jcm10071488

de Brouwer P, Bikker FJ, Brand HS, Kaman WE. Is TIMP-1 a biomarker for periodontal disease? A systematic review and meta-analysis. J Periodontal Res. 2021;57(2):235-45. doi: https://doi.org/10.1111/jre.12957

Deng K, Pelekos G, Jin L, Tonetti MS. Diagnostic accuracy of a point-of-care aMMP-8 test in the discrimi-nation of periodontal health and disease. J Clin Periodontol. 2021;48:1051-65. doi: https://doi.org/10.1111/jcpe.13485

Elashiry M, Morandini AC, Cornelius Timothius CJ, Ghaly M, Cutler CW. Selective antimicrobial therapies for periodontitis: win the “battle and the war”. Int. J. Mol. Sci. 2021;22:6459. doi: https://doi.org/10.3390/ijms22126459

Fastovets OO, Masheiko IV, Lucash AY. Eva-luation of bone resorptive potential in the treatment of generalized periodontitis. Wiad Lek. 2020;73(11):2396-402. doi: https://doi.org/10.36740/WLek202011112

Pan W, Wang Q, Chen Q. The cytokine network involved in the host immune response to periodontitis. Int J Oral Sci. 2019;11:30. doi: https://doi.org/10.1038/s41368-019-0064-z

Virtanen E, Yakob M, Tervahartiala T, Söder PÖ, Andersson LC, Sorsa T, et al. Salivary MMP-13 gender differences in periodontitis: A cross-sectional study from Sweden. Clin Exp Dent Res. 2017;3(5):165-70. doi: https://doi.org/10.1002/cre2.76

Опубликован

2022-09-30

Как цитировать

1.
 Samoilenko A, Titovska S. Matrix metalloproteinases in the oral fluid as a characteristic of inflammatory-destructive process in periodontal tissues. Med. perspekt. [Интернет]. 30 сентябрь 2022 г. [цитируется по 29 ноябрь 2024 г.];27(3):127-34. доступно на: https://journals.uran.ua/index.php/2307-0404/article/view/265959

Выпуск

Раздел

CLINICAL MEDICINE